HIVWomen
Meeting category
Date(s)
12 Apr 2024 - 13 Apr 2024
Location
Washington D.C., United States
Meeting type
Hybrid Meeting
Organizer
Titanium Level Sponsor
Sponsor logos
NIH 2023

International Workshop on HIV & Women 2024

Related Enduring Materials

Enduring Materials

Download Program

Download Program Book

Download Abstract Book

The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.

Session 1: Increasing the Burden: Impact of Global Crises on Women Living with HIV -
Overview of the Impact of the Global Climate Change Crisis on Infectious Diseases
Siegbert Rieg, MD
University Medical Center Freiburg, Germany
Refugees/Women Living with HIV on the Move - Implications for Management
Chioma Nnaji, MEd, MPH
Multicultural AIDS Coalition (MAC), United States
Session 2: Debate: ART Causes Hypertension in HIV -
Healthcare Provider: For the Proposition
Claudia Cortes, MD
University of Chile, Chile
Healthcare Provider: Against the Proposition
Jürgen Rockstroh, MD
University of Bonn, Germany
Community Representative: For the Proposition
Angelina Namiba, BA Hons
4MNetwork of Mentor Mothers, United Kingdom
Community Representative: Against the Proposition
Lucy Hutchinson
The Sussex Beacon, United Kingdom
NIH/OAR Supported Symposium: Breaking the Barriers to the Prevention and Treatment of HIV among Women -
Opening & Welcome
Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
Children’s National Hospital, United States
Kathleen Powis, MD
Harvard Medical School / Massachusetts General Hospital, United States
Mary Glenshaw, PhD, MPH
NIH Office of AIDS Research (OAR), United States
Avoiding Body Weight Bias in Healthcare for Women with HIV
Julie Schexnayder
University of Alabama at Birmingham, United States
Response
Amanda Willig, PhD, RD
University of Alabama at Birmingham, United States
HIV, PrEP Use and Related Biases among Adolescent Girls and Young Women in South Africa
Krishnaveni Surina Reddy, MMedSci
Wits Reproductive Health and HIV Institute (Wits RHI), South Africa
Response
Christina Psaros, PhD
Harvard Medical School / Massachusetts General Hospital, United States
PrEP Equity for Black Women - A "Dream Deferred” Becoming Reality
Latesha Elopre, MD, MSPH
University of Alabama at Birmingham, United States
Response
Abby Charles, MPH
Institute for Public Health Innovation (IPHI), United States
Closing
Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
Children’s National Hospital, United States
End of Symposium
Session 3: HIV and Co-Infections -
HIV and TB
Judith Kose, MD, PhD
Africa CDC, Eastern Africa Regional Coordinating Centre, Kenya
HPV and Cervical/Anal Cancer in Women with HIV
Deborah Money, MD, FRCSC
University of British Columbia, Canada
14:10
HIV and Long COVID
Simiso Sokhela, BSc, MBChB, Dip HIV Man
Ezintsha, University of the Witwatersrand, South Africa
#1 - Dynamic Interplay of High-Risk Human Papillomavirus in Women Living with HIV: Persistence, Clearance, Incidence and Synergies with Human T-lymphotropic Virus-1
James Kangethe
Kenya
#2 - Seroprevalence and Correlates of Co-infection With HIV and Active Syphilis Among Women in Six Sub-Saharan African Countries: Results From Population-Based HIV Impact Assessments (PHIAs)
Derrick Bary Abila
Uganda
#3 - Roll Out of Cervical Cancer Screening and Treatment Program; The Uganda’s Success Story
Josephine Ninsiima
Uganda
Industry Supported Symposium: People First Language - Why it Matters -
Introduction
Ama Appiah, BSc, MRPharmS
ViiV Healthcare, United Kingdom
What Is People-First Language, Why Does It Matter, and What Does It Mean for the HIV Community?
Yvonne Gilleece, MB, BCh, BAO
Brighton & Sussex Medical School and University Hospitals Sussex NHS Foundation Trust, United Kingdom
Angelina Namiba, BA Hons
4MNetwork of Mentor Mothers, United Kingdom
Marvelous Muchenje, BSW, MSc, PhD
ViiV Healthcare, Canada
End of the Symposium
Session 4: Pregnancy and Breastfeeding -
Infant Feeding Choices for Parents Living With HIV: Updates From the INFORM+ Forum Group
Natasha Davies, MD
Anova Health Institute, South Africa
8:50
Update on Use of Antiretrovirals in Pregnancy
Angela Colbers, PhD
Radboudumc, the Netherlands
#4 - Case Series of Women With HIV Who Breastfed
William Short
United States
#5 - Risk Factors for Preterm Birth in Pregnant Women Living With HIV: A 25-Year Analysis of the British Columbia Perinatal HIV Database
Jeffrey Man Hay Wong
Canada
#6 - Birth Defects Following Dolutegravir Transition among Women Delivering at Surveillance Sites in Eswatini
Philisiwe Ntombenhle Khumalo
Swaziland
#7 - The Health Outcomes Around Pregnancy and Exposure to HIV/ARVs (HOPE) Study: A Prospective Cohort of Reproductive-Aged Women Living With HIV
Deborah Kacanek
United States
Session 5: Where Do We Stand: Women Aging with HIV - from Research to Service Delivery -
Service Delivery for Women Aging with HIV
Luxey Sirisegaram, MD
University Health Network and Sinai Health Systems from University of Toronto, Canada
Cardiovascular Risk for Women - Data from the Reprieve Study
Sara E. Looby, PhD, ANP-BC, FAAN
Harvard Medical School / Massachusetts General Hospital, United States
Overview of Cardiovascular Diseases in Women
#8 - The CD38-NAD+ Axis Mediates a Hyperinflammatory State in WLWH
Poonam Mathur
United States
#9 - Sex Disparities in Geriatric Syndromes among People 50 Years or Older Receiving Care For HIV Infection in Mexico (2012-2017)
Yanink Caro-Vega
Mexico
Session 6: Abstract-Driven Presentations: Strategies for Prevention -
#10 - Antiretroviral Therapy Adherence Strategies for Women with HIV in the Postpartum Period
Florence Momplaisir
United States
#11 - EmpowerHER: Black Women's Reasons for HIV Prevention
Dana Williams
United States
#12 - HIV Sero-Conversions Among Adolescent Girl and Young Female Dapivirine Vaginal Ring (DPV-R) Users: Early Learnings From a Demonstration Project in Zimbabwe
Jabulani Mavudze
Zimbabwe
#13 - Factors Associated with Unawareness of HIV Status and Recency of HIV Infections among Women Living with HIV: Findings from a Population-Based Survey in Thirteen African Countries
Irene Mbabazi
Uganda
Session 7: Comorbidities and Women -
Appropriate Use of Hormonal Replacement Therapy During Menopause
Karoline Aebi-Popp, PD, MD, MSc
University Hospital Bern, Switzerland
Metabolic Complications - The Role of the New Weight Reduction Therapies
Todd Brown, MD, PhD
Johns Hopkins University, United States
Comorbidities in Trans Women
Kate Nambiar, MD, PhD
Terrence Higgins Trust, United Kingdom
General
About this Program
Group photo - HIV & Women 2024

The 14th International Workshop on HIV & Women took place in a hybrid format on 12 -13 April 2024 in Washington D.C., United States.

The 15th International Workshop on Women & HIV will take place in a hybrid format from 11-12 April 2025 in Barcelona, Spain.

The International Workshop on HIV & Women has now completed its 14th year and continues to evolve. It is an outstanding opportunity for healthcare providers, researchers, government, industry, and community representatives to discuss, debate, and further their knowledge on the issues related to HIV and women.

The format of the workshop enables attendees to learn from world-leading HIV experts and discuss the issues, gaps, and opportunities for further learning and research. Many of the attendees continue to participate each year and have formed valuable relationships and partnerships that have led to collaborative projects.

The enthusiasm and dedication of the participants is palpable throughout the workshop. The debates and roundtables are an important vehicle to discuss the issues and challenge dogmas.

Over the years, the number and quality of submitted abstracts have continued to improve. The workshop also provides a forum for early-career investigators to present their work and to personally meet with experts they view as mentors and inspirations for their work. The workshop considers both local and global issues and the information learnt in one setting is often translated into another.

We encourage you to consider joining us in 2024! 

On behalf of the Organizing Committee,

Workshop Chair
General Information 
Entry Requirements
Before your travel to the United States, we advise you to check the entry and visa requirements. You can find more information here: https://travel.state.gov/content/travel/en/us-visas.html
Uniques Features
- Two-day hybrid meeting
- Invited lectures from international experts
- Interactive roundtable sessions
- Ample time for discussion
Who Should Attend?
- HIV clinicians
- Researchers
- OBGYNs
- Government and NGO representatives
- Industry representatives
- Community advocates
- Pharmacists
- Medical Students
- Other healthcare providers involved in daily care of women living with HIV
Meeting Objectives
This meeting aims to:

- Facilitate an unbiased and scientific knowledge exchange regarding HIV & Women, and encourage early-career investigators to actively partake in the workshop;

- Summarize and promote the current state of the science regarding HIV & Women, and its successful translation and dissemination; and

- Foster new and lasting cross-disciplinary partnerships and collaborations between researchers and women to improve knowledge sharing, with the end goal of improving the quality of life of women living with HIV.
Learning Objectives
After participating in this activity, participants will be able to:

- Outline the disruptions that global crises brought to HIV service delivery;
- Describe the multiple facets of weight gain and metabolic complications following ART initiation;
- Discuss the updated guidelines for breastfeeding;
- Specify new treatments and prevention regimens for women living with HIV;
- Understand the interplay between HIV and comorbidities in aging women living with HIV.
Practical Information 
Venue
HIV & Women 2024 will take place at the The Mayflower Hotel: 1127 Connecticut Ave NW, Washington, DC 20036, United States
Accommodation
More information on accommodation can be found on the accommodation tab of the website.
Entry Requirements
All travelers arriving to the United States, are required to apply for a VISA or an Electronic System for Travel Authorisation (ESTA). To find out which one applies to you, please visit the US State Department Website: https://travel.state.gov/content/travel/en/us-visas/visa-information-resources/wizard.html
Badges
All participants are requested to wear the badge at all times during the workshop to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to participants after they successfully complete the program and post-meeting survey.
Language
The official language of the workshop is English.
Translation will not be provided.
Enduring Materials
Enduring materials will be available shortly after the conclusion of the workshop.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Committees
Organizing Committee

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee

The members of the Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

  • Karoline Aebi-Popp, PD, MD, MSc, University Hospital Bern, Switzerland
  • Sergii Antoniak, MD, Gromashevsky Institute of Epidemiology and Infectious Diseases, National Academy of Medical Sciences of Ukraine, Ukraine
  • Dawn Averitt, The Well Project/WRI, United States
  • Olga Belyaeva, Eurasian Network of People who Use Drugs (ENPUD), Ukraine
  • Marina Bobkova, MD, PhD, Gamaleya Center for Epidemiology and Microbiology, Russian Ministry of Health, Russia                     
  • Claudia Cortes, MD, University of Chile, Chile
  • Dazon Dixon Diallo, MPH, Sister Love, United States
  • Mirjam-Colette Kempf, MD, MPH, University of Alabama at Birmingham, United States
  • Justyna Kowalska, MD, PhD, Hospital for Infectious Diseases, Poland
  • Allen Kyendikuwa, BA, Uganda Youth Coalition on Adolescent SRHR and HIV (CYSRA), Uganda
  • Mona Loutfy, MD, FRCPC, MPH, Women's College Research Institute (Univ. Toronto), Canada
  • Mariana Mardarescu, MD, PhD, National Institute for Infectious Diseases "Prof. Dr. Matei Bals", Romania
  • Catia Marzolini, PharmD, PhD, University Hospital Basel, Switzerland
  • Deborah Money, MD, FRCSC, University of British Columbia, Canada
  • Teresia Otieno, ATHENA Network, United States
  • Lena Serghides, PhD, University Health Network, Canada
  • William R. Short, MD, MPH, FIDSA, University of Pennsylvania, United States
  • Shema Tariq, PhD, FRCP, University College London, United Kingdom
  • Patricia Vasquez, MD, Hospital San Juan de Dios, Chile
  • Marta Vasylyev, MD, Astar Medical Center, Ukraine
  • Markella Zanni, MD, MGH/Harvard Medical School, United States
Support
Scholarships Supporter
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals, researchers, and community representatives involved in the International Workshop on HIV & Women 2024.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Lara da Silva Miguel at Lara@amededu.com.
 
Benefits of Support 
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgment during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgment on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the conference bag 

 
*Subject to the support level

Endorsers
Accommodation
We look forward to welcoming you to Washington DC!

As you plan your trip to Washington DC, we want to make your stay is as comfortable and convenient as possible. Therefore, we are pleased to offer to all participants of HIV & Women 2024 a selection of accommodation options depending on your preferences and budget.

To benefit from a special discount on the best available rates, please book your accommodation through the following reservation links.

Reservation Links
Mayflower
The Mayflower Hotel
Expiration date: 21 March 2024
Marriott
Washington Marriott at Metro Center
Expiration date: 21 March 2024
Motto by Hilton Washington DC City Center
Motto by Hilton Washington DC City Center
Expiration date: 12 March 2024
capital hilton
Capital Hilton
Expiration date: 12 March 2024
Westin
The Westin Washington, D.C. City Center
Expiration date: 21 March 2024
Photo Gallery
Group Photo
 
Group photo - HIV & Women 2024

Previous Editions
Language
Ratings previous edition
I would recommend this workshop to my peers
4.8
(113)
Content was presented clearly
4.5
Content is relevant to my practice
4.5